GAYTAN CERVANTES, FRANCISCO JAVIER
CIENCIAS MÉDICAS · Nivel 1
Principal en Instituto Mexicano del Seguro Social
Información*
| Nombre | FRANCISCO JAVIER GAYTAN CERVANTES |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | CIENCIAS MÉDICAS |
| Disciplina | BIOLOGÍA HUMANA |
| Especialidad | BIOLOGIA MOLECULAR |
| CVU | 293958 |
| Institución | |
|---|---|
| Dependencia | NIVEL CENTRAL-INVESTIGACION |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2025 |
| Fin: 31/12/2029 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Últimas publicaciones Scopus
- 2026
- Methylation in the TAC1 Gene Promoter Is Associated with the Transition from Acute Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension International Journal of Molecular Sciences · Vol. 27 Article
- Mechanisms of Chemoresistance in Malignant Pleural Mesothelioma: The Regulatory Role of miRNAs Archives of Medical Research · Vol. 57 Review
- Pulmonary vascular resistance at hospital admission is associated with early mortality in patients with intermediate-to-high-risk acute pulmonary embolism Journal of Thrombosis and Thrombolysis Article
- Analysis of senescence in pituitary tumors from different lineages and the potential role of senolytic drugs as targeted therapies Frontiers in Endocrinology · Vol. 17 Article
- 2025
- Spatial transcriptomics reveal PI3K-AKT and metabolic alterations in aggressive, treatment-resistant lactotroph pituitary neuroendocrine tumors Acta Neuropathologica Communications · Vol. 13 Article